Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity
Shiv K. Singh(Universitätsmedizin Göttingen), Volker Ellenrieder, Albrecht Neeße(Universitätsklinikum Gießen und Marburg), Jochen Gaedcke(Universitätsmedizin Göttingen), William R. Bamlet(Mayo Clinic), Cornelia Brendel(Philipps University of Marburg), Elisabeth Heßmann(Universitätsmedizin Göttingen), Jin‐San Zhang(Wenzhou Medical University), Thomas C. Smyrk(Mayo Clinic in Arizona), Howard C. Crawford(Henry Ford Health System), Alexander Köenig(Universitätsmedizin Göttingen), Nai‐Ming Chen(University of Göttingen), Garima Singh(Dr. D. Y. Patil Medical College, Hospital and Research Centre), Thorsten Stiewe(Philipps University of Marburg), Iréne Esposito(Heinrich Heine University Düsseldorf), Marco Mernberger(Philipps University of Marburg), Jens T. Siveke(German Cancer Research Center), Daniel D. Billadeau(Mayo Clinic), Nadine Voelker(Philipps University of Marburg), Marlen Lahmann(Philipps University of Marburg), Xiaokun Li(Binzhou University), Matthias Hebrok(University of California, San Francisco), Ansgar Schmidt(Philipps University of Marburg), Sophia Vogt(Waldkrankenhaus Rudolf Elle)
Cited by 96
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Esophageal eosinophilia with dysphagia
|Digestive Diseases and Sciences|1993|889
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
|Journal of Cell Science|2001|688